G01N 2800/104
Lupus erythematosus [sle]
Official title: Lupus erythematosus [SLE]
G01N2800/104 (Lupus erythematosus [sle]) appears on 150 US grants and 306 published applications in this corpus.
Search patents in G01N- Granted patents
- 150
- Published applications
- 306
- Assignees
- 205
- Inventors
- 646
- Latest grant
- 3 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 3 | 3 |
| 2004 | 0 | 4 |
| 2005 | 3 | 6 |
| 2006 | 1 | 7 |
| 2007 | 2 | 9 |
| 2008 | 2 | 10 |
| 2009 | 5 | 9 |
| 2010 | 6 | 13 |
| 2011 | 6 | 19 |
| 2012 | 4 | 19 |
| 2013 | 7 | 15 |
| 2014 | 1 | 19 |
| 2015 | 4 | 9 |
| 2016 | 6 | 19 |
| 2017 | 8 | 19 |
| 2018 | 13 | 13 |
| 2019 | 11 | 24 |
| 2020 | 10 | 19 |
| 2021 | 7 | 11 |
| 2022 | 9 | 16 |
| 2023 | 4 | 14 |
| 2024 | 10 | 13 |
| 2025 | 7 | 8 |
| 2026 | 1 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-BCMA antibody, antigen-binding fragment thereof and medical use thereof3 Feb 2026US 12,540,190 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Diagnostic method for systemic lupus erythematosus using SMYD3 autoantibody16 Dec 2025US 12,498,369 B2Ajou University Industry-Academic Cooperation Foundation
- Methods for treating and diagnosing systemic lupus erythematosus21 Oct 2025US 12,449,427 B2Exagen Inc.
- Methods and compositions for treating and diagnosing autoimmune diseases26 Aug 2025US 12,397,046 B2New York University
- Method for detecting a binding of antibodies from a patient sample to double-stranded DNA using Crithidia luciliae cells and fluorescence microscopy29 Jul 2025US 12,372,532 B2EUROIMMUN Medizinische Labordiagnostika AG
- Genetic testing for early detection of autoimmune diseases6 Aug 2026US 2026/0226547 A1New York Society for the Relief of the Ruptured and Crippled, maintaining the Hospital for Special S
- Protein biomarkers for use in lupus nephritis21 May 2026US 2026/0140113 A1Exagen Inc.
- Compositions and methods for treating inflammatory diseases14 May 2026US 2026/0133193 A1University of Washington
- Methods for identifying subjects at risk of thrombosis or malignancy16 Apr 2026US 2026/0104419 A1The Johns Hopkins University
- Biomarkers For A Systemic Lupus Erythematosus (SLE) Disease Activity Immune Index That Characterizes Disease Activity5 Mar 2026US 2026/0063632 A1Oklahoma Medical Research Foundation
Most cited
By later US patents
- Hepcidins as biomarkers for impending lupus nephritis flare32US 8,313,950 B2The Ohio State University Research Foundation · 2012
- Liposome composition for lupus assay26US 4,668,638 AThe Liposome Company, Inc. · 1987
- Assays and treatments of autoimmune diseases24US 5,637,454 AOklahoma Medical Research Foundation · 1997
- Methods of diagnosing and monitoring rheumatic diseases23US 5,340,720 AUniversity of Kansas · 1994
- Compositions and methods for treating inflammation and auto-immune diseases21US 7,931,896 B2The Johns Hopkins University · 2011